Trump Officials Review Biden-Era Funding For Moderna Bird Flu Vaccine Contract
US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...
Moderna, Inc.: Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...
Moderna receives MHRA marketing authorization for RSV vaccine
Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...
New vaccine approved in over-60s - jab uses mRNA technology like Covid
The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...
UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
BioSpace16hOpinion
Opinion: How mRNA Can Help Bridge the Innovation Gap in Rare Disease
As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...
The European Medicines Agency EMA has not 'admitted' that mRNA vaccines are 'experimental'
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...
Honolulu Star-Advertiser1d
Trump team weighs pulling funds for bird flu vaccine
U.S. health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
HHS weighs rescinding Moderna bird flu vaccine contract
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...